orBec News
Most Popular orBec Story
UPDATED: Soligenix shares decimated on repeat failure for orBec Ph3
Princeton, NJ-based Soligenix ($SGNX) called a sudden halt to its late-stage study of orBec--an oral formulation of beclomethasone dipropionate for acute gastrointestinal Graft-versus-Host Read more...
Latest Headlines
- September 15, 2011
- October 19, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
